Category: Intellectual property
-
Ordinary Smartphones Able to Hack 3-D Printers
A hacker with an everyday smartphone can steal design data from three-dimensional printers, according to a new paper from a university computer science group.
-
Small Molecule Drug Discovery Patent Issued
A company developing small-molecule treatments for biological targets considered difficult to address is receiving a patent for its core drug identification technology.
-
Patent Set for Heart Tissue Regeneration Drug
A drug developed by MDI Biological Laboratory that stimulates growth of heart tissue to fix damage from heart attacks is scheduled to receive a U.S. patent.
-
University Spin-Off Developing Sepsis Drug
A spin-off enterprise from University of British Columbia is licensing a cholesterol-lowering drug from drug maker Novartis to develop a treatment for sepsis and other severe infections.
-
Patent Advances for Gut Damage Treatment Delivery
A developer of therapies for damage to an intestinal barrier received a notice that the U.S. intends to issue a patent protecting the technology to deliver the treatments.
-
University Spin-Off Developing Chemical ID Devices
A start-up company is licensing research from labs at Harvard University to make portable devices that quickly identify the chemistry of liquids.
-
Amgen, Advaxis Partner on Personal Cancer Immunotherapy
Biological drug maker Amgen is licensing precision immunotherapy technology from Advaxis Inc. to develop treatments for cancer.
-
Univ. Spin-Off Develops New Cybersecurity Paradigm
A start-up enterprise from a university is developing a simplified cybersecurity infrastructure for businesses, and raised $2 million in its first funding round
-
Device Measuring Nerves on Heart Rhythm in Development
22 July 2016. A spin-off enterprise from Indiana University is creating a device to measure sympathetic nerve activity — the fight-or-flight response — in people with heart rhythm disorders. Research and development of a prototype device, by Arrhythmotech LLC in Indianapolis, is funded by a new 2-year, $1.47 million grant from National Institute of Drug…
-
RNA Technology Licensed for Cystic Fibrosis Therapy
Two biotechnology companies are collaborating on treatments for cystic fibrosis that use genetic material to address underlying causes of the inherited disease.